Healthcare Sector Stocks
The Healthcare sector has a total of 1049 stocks, with a combined market cap of $10.11 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.48.
Market Cap
10.11T
Revenue
4.74T
Profits
212.86B
PE Ratio
47.48
Profit Margin
4.49%
Dividend Yield
0.37%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.28T | 1.44% | 3,020,713 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 675.92B | -0.47% | 7,385,631 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 519.48B | 0.20% | 3,520,638 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 364.98B | -0.48% | 5,511,240 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 363.00B | 1.89% | 4,458,818 | 450.06B |
| 6 | NVS | Novartis AG | 307.30B | -0.26% | 1,979,242 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 286.90B | -1.39% | 1,803,197 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 266.10B | -0.48% | 1,792,970 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.65B | - | 2,139,565 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 211.94B | 0.92% | 4,830,595 | 30.99B |
| 11 | ABT | Abbott Laboratories | 191.31B | -0.05% | 7,377,934 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.54B | -1.64% | 6,530,887 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.35B | 0.44% | 31,128,745 | 63.62B |
| 14 | DHR | Danaher Corporation | 166.11B | 0.42% | 3,396,150 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.00B | -2.28% | 1,664,878 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.91B | -0.54% | 1,239,295 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.37B | 1.06% | 7,617,380 | 50.03B |
| 18 | MCK | McKesson Corporation | 124.99B | 2.19% | 605,200 | 418.79B |
| 19 | MDT | Medtronic plc | 124.36B | -1.17% | 5,053,515 | 37.54B |
| 20 | SYK | Stryker Corporation | 123.45B | -0.44% | 2,637,685 | 26.30B |
| 21 | SNY | Sanofi | 114.82B | 0.23% | 4,597,197 | 57.89B |
| 22 | CVS | CVS Health Corporation | 113.89B | 4.41% | 15,116,052 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 105.37B | -0.09% | 1,088,563 | 78.70B |
| 24 | GSK | GSK plc | 102.39B | -0.60% | 2,623,587 | 44.53B |
| 25 | MRNA | Moderna, Inc. | 101.49B | -6.75% | 11,149,939 | 2.53B |
| 26 | ELV | Elevance Health, Inc. | 92.83B | 2.73% | 906,308 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 91.92B | -0.42% | 517,080 | 16.90B |
| 28 | CI | The Cigna Group | 79.88B | 2.55% | 1,488,619 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.13B | -0.76% | 2,951,941 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.54B | 0.85% | 1,078,563 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 64.79B | 1.54% | 11,713,596 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 63.98B | 0.91% | 1,601,113 | 257.75B |
| 33 | ARGX | argenx SE | 60.26B | 0.96% | 434,071 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 59.81B | -0.67% | 3,777,302 | 6.67B |
| 35 | BDX | Becton, Dickinson and Company | 57.91B | -1.23% | 1,790,254 | 19.46B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 54.89B | -1.42% | 463,973 | 4.66B |
| 37 | MDLN | Medline Inc. | 53.81B | 0.49% | 7,435,849 | 30.68B |
| 38 | HUM | Humana Inc. | 52.61B | 3.51% | 2,108,953 | 154.19B |
| 39 | A | Agilent Technologies, Inc. | 50.15B | -1.27% | 2,059,672 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 49.47B | -1.33% | 6,223,961 | 17.23B |
| 41 | VEEV | Veeva Systems Inc. | 49.47B | -0.28% | 1,073,620 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 48.43B | 1.60% | 599,344 | 6.45B |
| 43 | WAT | Waters Corporation | 46.72B | -0.25% | 889,329 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 45.34B | -1.32% | 1,001,584 | 17.31B |
| 45 | NTRA | Natera, Inc. | 45.24B | -2.62% | 1,751,255 | 2.91B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.76B | -3.54% | 2,069,699 | 197.56M |
| 47 | RPRX | Royalty Pharma plc | 39.84B | 0.99% | 3,421,424 | 2.62B |
| 48 | HLN | Haleon plc | 39.24B | 1.00% | 17,099,212 | 14.80B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.82B | -0.45% | 2,984,781 | 21.64B |
| 50 | BIIB | Biogen Inc. | 37.44B | -0.64% | 735,027 | 10.30B |
| 51 | ALC | Alcon Inc. | 36.19B | -1.44% | 5,331,775 | 10.98B |
| 52 | MTD | Mettler-Toledo International Inc. | 34.84B | -0.62% | 153,359 | 4.20B |
| 53 | CNC | Centene Corporation | 34.75B | 2.41% | 6,218,356 | 180.41B |
| 54 | GMAB | Genmab A/S | 33.80B | -3.10% | 3,093,364 | 4.30B |
| 55 | ZTS | Zoetis Inc. | 33.50B | 0.17% | 4,894,311 | 9.49B |
| 56 | RMD | ResMed Inc. | 32.93B | -0.69% | 1,197,142 | 5.73B |
| 57 | ILMN | Illumina, Inc. | 32.49B | -2.66% | 1,363,481 | 4.54B |
| 58 | LH | Labcorp Holdings Inc. | 30.12B | -0.26% | 510,426 | 14.59B |
| 59 | ROIV | Roivant Sciences Ltd. | 29.84B | 1.28% | 10,589,924 | 41.08M |
| 60 | DXCM | DexCom, Inc. | 29.81B | -1.42% | 3,098,780 | 5.10B |
| 61 | PHG | Koninklijke Philips N.V. | 29.50B | -1.23% | 1,360,487 | 20.16B |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.74B | -0.07% | 455,140 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.43B | -0.47% | 722,376 | 11.84B |
| 64 | INSM | Insmed Incorporated | 26.21B | 2.92% | 3,346,742 | 1.52B |
| 65 | UTHR | United Therapeutics Corporation | 25.07B | 1.06% | 461,369 | 3.19B |
| 66 | STE | STERIS plc | 24.97B | 0.07% | 934,239 | 6.17B |
| 67 | INCY | Incyte Corporation | 24.52B | -1.30% | 1,797,817 | 6.01B |
| 68 | VTRS | Viatris Inc. | 23.90B | 1.76% | 11,182,029 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.10B | 0.44% | 879,214 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.62B | -0.34% | 693,534 | 2.75B |
| 71 | GH | Guardant Health, Inc. | 21.02B | -2.17% | 2,429,904 | 1.28B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 20.31B | -0.93% | 1,842,122 | 8.57B |
| 73 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.31B | -3.17% | 2,455,636 | 5.01B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.59B | -1.25% | 165,204 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.75B | -1.01% | 1,148,678 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.22B | -1.62% | 5,583,516 | 2.50B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 17.12B | 0.17% | 1,058,505 | 3.70B |
| 78 | ASND | Ascendis Pharma A/S | 16.85B | -1.25% | 829,563 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.57B | -2.13% | 822,080 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.75B | 0.77% | 576,714 | 4.72B |
| 81 | ICLR | ICON Public Limited Company | 15.33B | -1.43% | 617,114 | 8.23B |
| 82 | BBIO | BridgeBio Pharma, Inc. | 15.32B | 0.95% | 3,284,757 | 945.54M |
| 83 | SOLV | Solventum Corporation | 15.29B | -0.39% | 1,245,269 | 8.16B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 15.10B | 4.83% | 2,940,322 | 15.25B |
| 85 | TEM | Tempus AI, Inc. | 14.69B | -4.62% | 4,973,953 | 1.51B |
| 86 | SMMT | Summit Therapeutics Inc. | 14.26B | -0.06% | 4,506,291 | - |
| 87 | EHC | Encompass Health Corporation | 13.98B | 0.96% | 1,001,771 | 6.34B |
| 88 | GKOS | Glaukos Corporation | 13.98B | -1.07% | 847,918 | 690.33M |
| 89 | BAX | Baxter International Inc. | 13.67B | 0.04% | 3,830,325 | 11.61B |
| 90 | ELAN | Elanco Animal Health Incorporated | 13.38B | -0.30% | 5,198,825 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.70B | -0.42% | 2,352,561 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.67B | -0.12% | 242,379 | 1.56B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.31B | -1.26% | 1,799,068 | 3.44B |
| 94 | ALGN | Align Technology, Inc. | 12.28B | - | 1,908,448 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 12.09B | -0.56% | 1,771,651 | 4.24B |
| 96 | FMS | Fresenius Medical Care AG | 11.78B | -0.92% | 1,396,224 | 22.12B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.74B | 0.06% | 2,251,954 | 1.80B |
| 98 | KYMR | Kymera Therapeutics, Inc. | 11.67B | -1.60% | 995,602 | 102.24M |
| 99 | TECH | Bio-Techne Corporation | 11.44B | -0.01% | 3,239,571 | 1.23B |
| 100 | DVA | DaVita Inc. | 11.28B | -3.37% | 963,934 | 14.17B |
| 101 | UHS | Universal Health Services, Inc. | 11.27B | -0.89% | 533,501 | 18.35B |
| 102 | RGEN | Repligen Corporation | 11.12B | -2.77% | 678,646 | 805.61M |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | -0.09% | 1,430,539 | 3.66B |
| 104 | MOH | Molina Healthcare, Inc. | 10.75B | 1.48% | 726,156 | 42.08B |
| 105 | ENSG | The Ensign Group, Inc. | 10.71B | 1.64% | 269,194 | 5.67B |
| 106 | AVTR | Avantor, Inc. | 10.55B | -2.14% | 6,345,792 | 6.64B |
| 107 | PCVX | Vaxcyte, Inc. | 10.50B | -1.73% | 1,268,829 | - |
| 108 | QGEN | Qiagen N.V. | 10.43B | -0.08% | 5,322,637 | 2.12B |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.39B | -0.47% | 210,960 | 2.59B |
| 110 | OSCR | Oscar Health, Inc. | 10.39B | 4.14% | 4,252,242 | 17.47B |
| 111 | PODD | Insulet Corporation | 10.27B | -1.17% | 1,077,220 | 3.19B |
| 112 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.05B | -0.04% | 459,039 | 1.43B |
| 113 | HNGE | Hinge Health, Inc. | 10.02B | 0.85% | 1,374,343 | 800.82M |
| 114 | GMED | Globus Medical, Inc. | 9.97B | -1.49% | 1,847,504 | 3.14B |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.92B | -4.15% | 1,003,967 | - |
| 116 | HSIC | Henry Schein, Inc. | 9.81B | 0.37% | 981,214 | 13.73B |
| 117 | BRKR | Bruker Corporation | 9.51B | -6.46% | 2,884,224 | 3.51B |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 9.44B | 1.39% | 518,152 | 7.46M |
| 119 | ATR | AptarGroup, Inc. | 9.14B | -0.01% | 438,252 | 3.99B |
| 120 | KRYS | Krystal Biotech, Inc. | 9.08B | 1.14% | 196,378 | 470.03M |
| 121 | TGTX | TG Therapeutics, Inc. | 9.00B | 1.39% | 5,790,737 | 897.76M |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.89B | 0.26% | 528,492 | 551.69M |
| 123 | HQY | HealthEquity, Inc. | 8.56B | 1.40% | 641,759 | 1.36B |
| 124 | TWST | Twist Bioscience Corporation | 8.29B | -2.37% | 1,719,274 | 431.80M |
| 125 | TXG | 10x Genomics, Inc. | 8.27B | -3.31% | 2,473,829 | 618.58M |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.03B | -2.24% | 1,341,107 | 963.65M |
| 127 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.90B | 0.01% | 616,032 | 280.75M |
| 128 | CYTK | Cytokinetics, Incorporated | 7.83B | 1.89% | 2,357,598 | 113.29M |
| 129 | ALKS | Alkermes plc | 7.81B | 0.65% | 1,035,991 | 1.75B |
| 130 | ABVX | ABIVAX Société Anonyme | 7.81B | 3.45% | 1,077,439 | 5.33M |
| 131 | PACS | PACS Group, Inc. | 7.79B | 0.68% | 700,992 | 5.71B |
| 132 | BLCO | Bausch + Lomb Corporation | 7.64B | 1.96% | 1,502,263 | 5.42B |
| 133 | GRFS | Grifols, S.A. | 7.60B | 0.81% | 1,045,318 | 8.63B |
| 134 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.47B | -3.79% | 631,655 | 945.96M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.45B | 0.47% | 2,363,732 | 3.20B |
| 136 | ORKA | Oruka Therapeutics, Inc. | 7.43B | 4.72% | 2,611,589 | - |
| 137 | AXSM | Axsome Therapeutics, Inc. | 7.42B | 5.23% | 1,285,598 | 865.27M |
| 138 | IMVT | Immunovant, Inc. | 7.39B | 1.59% | 1,644,284 | - |
| 139 | MTRI | Mentari Therapeutics, Inc. | 7.33B | -23.75% | 57,481 | - |
| 140 | IBRX | ImmunityBio, Inc. | 7.18B | -5.13% | 20,043,032 | 182.57M |
| 141 | CHE | Chemed Corporation | 7.06B | 1.20% | 131,708 | 2.66B |
| 142 | CAI | Caris Life Sciences, Inc. | 7.01B | -4.46% | 5,074,735 | 1.05B |
| 143 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.92B | -0.49% | 2,637,109 | 669.50M |
| 144 | KOD | Kodiak Sciences Inc. | 6.78B | 0.90% | 590,238 | - |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.65B | 0.60% | 1,264,886 | 1.56B |
| 146 | CGON | CG Oncology, Inc. | 6.49B | -2.81% | 821,633 | 6.17M |
| 147 | BLTE | Belite Bio, Inc | 6.30B | -0.74% | 177,021 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.28B | - | 172,561 | 253.83M |
| 149 | MANE | Veradermics, Incorporated | 6.26B | 3.12% | 599,794 | - |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 6.16B | 1.33% | 626,646 | 670.78M |
| 151 | TFX | Teleflex Incorporated | 6.16B | 0.37% | 748,058 | 2.26B |
| 152 | RDNT | RadNet, Inc. | 6.14B | -0.56% | 661,490 | 2.38B |
| 153 | SUPN | Supernus, Inc. | 5.97B | 4.09% | 2,784,895 | 1.37B |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.85B | -6.89% | 2,061,000 | 570.00K |
| 155 | DOCS | Doximity, Inc. | 5.78B | -1.37% | 2,134,706 | 661.58M |
| 156 | WAY | Waystar Holding Corp. | 5.64B | 0.41% | 1,213,321 | 1.26B |
| 157 | GRAL | GRAIL, Inc. | 5.61B | -2.61% | 667,991 | 166.60M |
| 158 | HAE | Haemonetics Corporation | 5.57B | 3.51% | 797,948 | 1.38B |
| 159 | LFST | LifeStance Health Group, Inc. | 5.54B | -0.27% | 24,089,367 | 1.68B |
| 160 | COGT | Cogent Biosciences, Inc. | 5.51B | -5.66% | 2,850,355 | - |
| 161 | ERAS | Erasca, Inc. | 5.41B | -0.83% | 5,985,045 | - |
| 162 | CON | Concentra Group Holdings Parent, Inc. | 5.40B | 0.64% | 775,929 | 2.34B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.36B | -1.37% | 630,009 | 1.16B |
| 164 | BLLN | BillionToOne, Inc. | 5.35B | -2.57% | 976,608 | 436.87M |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.26B | -0.69% | 480,465 | 1.61B |
| 166 | EWTX | Edgewise Therapeutics, Inc. | 5.09B | -4.53% | 1,939,842 | - |
| 167 | LIVN | LivaNova PLC | 5.02B | -1.59% | 754,137 | 1.51B |
| 168 | DNTH | Dianthus Therapeutics, Inc. | 5.00B | -1.32% | 523,654 | 2.72M |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.99B | 0.70% | 1,105,154 | 651.03M |
| 170 | MMED | MiniMed Group, Inc. | 4.88B | -2.91% | 4,453,317 | 3.22B |
| 171 | HTFL | HeartFlow, Inc. | 4.85B | -1.52% | 1,276,820 | 212.07M |
| 172 | ADPT | Adaptive Biotechnologies Corporation | 4.75B | -2.97% | 1,849,491 | 298.01M |
| 173 | DFTX | Definium Therapeutics, Inc. | 4.74B | -2.12% | 1,295,859 | - |
| 174 | OPCH | Option Care Health, Inc. | 4.74B | -0.13% | 1,411,848 | 5.75B |
| 175 | IONS | Ionis Pharmaceuticals, Inc. | 4.69B | -9.06% | 10,692,786 | 960.09M |
| 176 | SHC | Sotera Health Company | 4.65B | -1.03% | 2,012,081 | 1.23B |
| 177 | LQDA | Liquidia Corporation | 4.63B | 7.37% | 2,848,619 | 621.87M |
| 178 | ICUI | ICU Medical, Inc. | 4.55B | 1.82% | 270,311 | 2.18B |
| 179 | HIMS | Hims & Hers Health, Inc. | 4.48B | -16.61% | 58,757,484 | 2.87B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.41B | -2.21% | 2,402,220 | 10.35M |
| 181 | CRSP | CRISPR Therapeutics AG | 4.38B | -9.77% | 4,013,874 | 25.17M |
| 182 | ITGR | Integer Holdings Corporation | 4.30B | 0.05% | 673,101 | 1.83B |
| 183 | CDNA | CareDx, Inc. | 4.24B | -4.32% | 1,036,813 | 497.40M |
| 184 | NVST | Envista Holdings Corporation | 4.14B | -0.50% | 2,192,061 | 2.88B |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.12B | 6.86% | 4,560,778 | 53.81M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 4.07B | 2.32% | 2,088,684 | 7.50M |
| 187 | PLSE | Pulse Biosciences, Inc. | 4.05B | -5.24% | 496,319 | 1.49M |
| 188 | ABCL | AbCellera Biologics Inc. | 4.04B | -0.32% | 3,913,149 | 67.85M |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.97B | 2.32% | 1,424,757 | -665.00K |
| 190 | LEGN | Legend Biotech Corporation | 3.95B | -15.97% | 6,380,563 | 1.36B |
| 191 | IRON | Disc Medicine, Inc. | 3.85B | 4.16% | 1,925,578 | - |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.77B | -0.68% | 951,735 | - |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | -1.10% | 10,058,116 | 378.98M |
| 194 | WRBY | Warby Parker Inc. | 3.72B | -1.03% | 5,737,281 | 934.66M |
| 195 | PBLS | Parabilis Medicines, Inc. | 3.71B | -1.15% | 502,428 | 148.00K |
| 196 | STVN | Stevanato Group S.p.A. | 3.70B | -1.46% | 476,539 | 1.42B |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.65B | -1.14% | 4,260,188 | - |
| 198 | OGN | Organon & Co. | 3.65B | 0.29% | 2,355,747 | 6.10B |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.64B | 4.22% | 859,010 | 682.20M |
| 200 | ACHC | Acadia Healthcare Company, Inc. | 3.59B | 0.08% | 3,630,719 | 3.41B |
| 201 | VRDN | Viridian Therapeutics, Inc. | 3.50B | 2.22% | 2,713,879 | 26.31M |
| 202 | SGRY | Surgery Partners, Inc. | 3.47B | 1.06% | 7,309,567 | 3.36B |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 4.52% | 2,223,705 | 508.68M |
| 204 | DYN | Dyne Therapeutics, Inc. | 3.36B | -3.76% | 2,392,705 | - |
| 205 | CELC | Celcuity Inc. | 3.29B | -4.72% | 769,804 | - |
| 206 | NHC | National HealthCare Corporation | 3.27B | -0.56% | 96,053 | 1.58B |
| 207 | TLX | Telix Pharmaceuticals Limited | 3.26B | -4.45% | 161,444 | 890.79M |
| 208 | DNLI | Denali Therapeutics Inc. | 3.18B | -2.36% | 975,854 | 21.38M |
| 209 | ACAD | Acadia Pharmaceuticals Inc. | 3.16B | 10.79% | 6,354,161 | 1.20B |
| 210 | TMDX | TransMedics Group, Inc. | 3.16B | -3.03% | 1,626,368 | 727.65M |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 3.16B | 6.02% | 1,184,497 | 1.46B |
| 212 | PRVA | Privia Health Group, Inc. | 3.11B | -0.69% | 1,082,594 | 2.43B |
| 213 | BHC | Bausch Health Companies Inc. | 3.10B | -1.31% | 2,450,866 | 11.11B |
| 214 | IDYA | IDEAYA Biosciences, Inc. | 3.07B | -0.87% | 950,301 | 36.54M |
| 215 | AXGN | Axogen, Inc. | 3.04B | 0.49% | 1,105,760 | 266.93M |
| 216 | VCEL | Vericel Corporation | 3.01B | 1.10% | 1,331,160 | 324.17M |
| 217 | ZLAB | Zai Lab Limited | 2.97B | -1.60% | 1,531,722 | 441.73M |
| 218 | XNCR | Xencor, Inc. | 2.96B | 2.07% | 1,187,840 | 200.49M |
| 219 | IRTC | iRhythm Holdings, Inc. | 2.89B | -3.01% | 1,210,062 | 854.04M |
| 220 | XERS | Xeris Biopharma Holdings, Inc. | 2.89B | -0.19% | 3,779,407 | 368.26M |
| 221 | AVAH | Aveanna Healthcare Holdings Inc. | 2.88B | -0.08% | 1,355,939 | 2.60B |
| 222 | ATRC | AtriCure, Inc. | 2.86B | -2.63% | 838,175 | 589.80M |
| 223 | ADMA | ADMA Biologics, Inc. | 2.81B | -0.94% | 3,312,254 | 519.15M |
| 224 | MBX | MBX Biosciences, Inc. | 2.80B | 4.20% | 1,124,407 | - |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.69B | -1.48% | 1,152,277 | 100.00M |
| 226 | PGNY | Progyny, Inc. | 2.68B | 1.34% | 1,419,439 | 1.34B |
| 227 | CLOV | Clover Health Investments, Corp. | 2.64B | 2.07% | 3,782,042 | 2.74B |
| 228 | HCM | HUTCHMED (China) Limited | 2.63B | 0.39% | 13,985 | 549.12M |
| 229 | RGC | Regencell Bioscience Holdings Limited | 2.59B | -7.10% | 142,785 | - |
| 230 | NEOG | Neogen Corporation | 2.55B | -3.39% | 1,755,336 | 884.00M |
| 231 | ARDT | Ardent Health, Inc. | 2.53B | -0.22% | 747,227 | 6.45B |
| 232 | BEAM | Beam Therapeutics Inc. | 2.51B | -6.92% | 3,115,601 | 146.64M |
| 233 | SEPN | Septerna, Inc. | 2.49B | 3.15% | 537,692 | 96.27M |
| 234 | PVLA | Palvella Therapeutics, Inc. | 2.47B | -3.08% | 373,400 | - |
| 235 | SDGR | Schrödinger, Inc. | 2.43B | -2.94% | 1,779,788 | 269.20M |
| 236 | UFPT | UFP Technologies, Inc. | 2.43B | -1.51% | 76,063 | 649.52M |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.41B | 0.41% | 536,369 | 1.96B |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.41B | -1.89% | 820,673 | 158.00K |
| 239 | PHVS | Pharvaris N.V. | 2.39B | -1.39% | 745,422 | - |
| 240 | PRGO | Perrigo Company plc | 2.34B | -0.71% | 2,109,484 | 4.09B |
| 241 | ADUS | Addus HomeCare Corporation | 2.31B | 3.16% | 225,846 | 1.50B |
| 242 | NAMS | NewAmsterdam Pharma Company N.V. | 2.30B | 0.95% | 2,361,986 | 25.94M |
| 243 | BHVN | Biohaven Ltd. | 2.28B | -0.79% | 1,781,021 | - |
| 244 | VIR | Vir Biotechnology, Inc. | 2.25B | -3.66% | 1,300,557 | 302.80M |
| 245 | BKD | Brookdale Senior Living Inc. | 2.24B | 0.75% | 13,306,667 | 2.86B |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | -6.70% | 19,099,841 | 68.23M |
| 247 | REPL | Replimune Group, Inc. | 2.21B | 4.58% | 3,019,160 | - |
| 248 | IMNM | Immunome, Inc. | 2.20B | -3.67% | 1,253,793 | 4.02M |
| 249 | TRAX | First Tracks Biotherapeutics, Inc. | 2.20B | 5.29% | 1,150,318 | - |
| 250 | NEO | NeoGenomics, Inc. | 2.19B | -3.64% | 1,758,998 | 787.75M |
| 251 | ALMR | Alamar Biosciences, Inc. | 2.19B | -1.07% | 468,999 | 114.05M |
| 252 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.93% | 813,866 | 321.74M |
| 253 | ZYME | Zymeworks Inc. | 2.17B | 2.11% | 1,687,595 | 265.97M |
| 254 | VERA | Vera Therapeutics, Inc. | 2.17B | -1.89% | 1,852,125 | 10.28M |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.14B | 0.73% | 953,943 | 1.08B |
| 256 | PBH | Prestige Consumer Healthcare Inc. | 2.13B | 2.98% | 545,278 | 1.17B |
| 257 | TRVI | Trevi Therapeutics, Inc. | 2.13B | -2.61% | 2,322,968 | - |
| 258 | LKFT | Lakefront Biotherapeutics NV | 2.10B | -0.33% | 228,631 | 1.13B |
| 259 | FTRE | Fortrea Holdings Inc. | 2.06B | -3.82% | 1,335,336 | 2.67B |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.04B | -2.00% | 1,745,451 | 213.00M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 2.01B | -1.88% | 391,328 | 264.03M |
| 262 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -0.68% | 1,326,804 | 989.36M |
| 263 | ETON | Eton Pharmaceuticals, Inc. | 1.95B | 4.96% | 1,176,170 | 141.06M |
| 264 | VCYT | Veracyte, Inc. | 1.94B | -7.18% | 4,464,314 | 581.78M |
| 265 | MAZE | Maze Therapeutics, Inc. | 1.94B | 1.55% | 1,136,209 | 20.00M |
| 266 | ZBIO | Zenas BioPharma, Inc. | 1.94B | 0.04% | 304,670 | 11.00M |
| 267 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.94B | -1.31% | 4,047,182 | 961.51M |
| 268 | XRAY | DENTSPLY SIRONA Inc. | 1.92B | 1.68% | 6,020,948 | 3.58B |
| 269 | AGL | agilon health, inc. | 1.91B | -0.44% | 148,811 | 6.00B |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | 1.21% | 1,005,369 | 140.84M |
| 271 | CERT | Certara, Inc. | 1.85B | -0.78% | 2,880,174 | 425.76M |
| 272 | KLRA | Kailera Therapeutics, Inc. | 1.85B | 3.94% | 1,182,703 | - |
| 273 | COAG | Hemab Therapeutics Holdings, Inc. | 1.81B | -9.44% | 817,140 | - |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -2.64% | 293,303 | 269.36M |
| 275 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 3.10% | 239,519 | 4.44M |
| 276 | MESO | Mesoblast Limited | 1.81B | -3.12% | 90,296 | 120.25M |
| 277 | INSP | Inspire Medical Systems, Inc. | 1.80B | -3.14% | 401,959 | 880.94M |
| 278 | STOK | Stoke Therapeutics, Inc. | 1.78B | -1.80% | 838,277 | 28.21M |
| 279 | AZTA | Azenta, Inc. | 1.77B | -1.15% | 675,895 | 621.70M |
| 280 | GENB | Generate Biomedicines, Inc. | 1.77B | -2.82% | 530,081 | 26.48M |
| 281 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -4.76% | 3,361,957 | 1.96B |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.76B | -1.89% | 289,319 | 106.73M |
| 283 | ALVO | Alvotech | 1.74B | 4.05% | 946,937 | 494.61M |
| 284 | BFLY | Butterfly Network, Inc. | 1.74B | -2.40% | 4,275,018 | 123.26M |
| 285 | NRIX | Nurix Therapeutics, Inc. | 1.73B | -1.61% | 3,049,892 | 701.94M |
| 286 | PSNL | Personalis, Inc. | 1.72B | -0.44% | 1,755,224 | 80.77M |
| 287 | ABSI | Absci Corporation | 1.71B | -7.69% | 4,102,715 | 1.56M |
| 288 | HCSG | Healthcare Services Group, Inc. | 1.71B | 2.10% | 574,646 | 1.88B |
| 289 | SLS | SELLAS Life Sciences Group, Inc. | 1.69B | -2.45% | 3,927,113 | - |
| 290 | NVAX | Novavax, Inc. | 1.68B | -6.34% | 12,268,285 | 411.65M |
| 291 | IMCR | Immunocore Holdings plc | 1.67B | 2.05% | 791,963 | 429.30M |
| 292 | OMCL | Omnicell, Inc. | 1.65B | -3.88% | 560,198 | 1.24B |
| 293 | ASTH | Astrana Health, Inc. | 1.65B | -4.71% | 515,312 | 3.91B |
| 294 | NBTX | Nanobiotix S.A. | 1.64B | 2.62% | 49,715 | 13.15M |
| 295 | WGS | GeneDx Holdings Corp. | 1.64B | -16.57% | 3,362,009 | 460.78M |
| 296 | RARE | Ultragenyx Pharmaceutical Inc. | 1.64B | -1.65% | 5,464,849 | 730.00M |
| 297 | SNDA | Sonida Senior Living, Inc. | 1.63B | 1.57% | 380,555 | 593.56M |
| 298 | TDOC | Teladoc Health, Inc. | 1.63B | -0.45% | 4,901,021 | 2.47B |
| 299 | ENOV | Enovis Corporation | 1.63B | -1.12% | 1,596,583 | 2.31B |
| 300 | PGEN | Precigen, Inc. | 1.62B | -4.44% | 6,031,738 | 156.94M |
| 301 | ALHC | Alignment Healthcare, Inc. | 1.61B | 5.50% | 4,352,274 | 4.94B |
| 302 | BRVE | Braveheart Bio, Inc. | 1.60B | 0.82% | 211,467 | - |
| 303 | QURE | uniQure N.V. | 1.59B | -0.35% | 1,137,485 | 20.17M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -7.76% | 4,207,931 | 52.89M |
| 305 | GPCR | Structure Therapeutics Inc. | 1.55B | 1.49% | 1,443,835 | - |
| 306 | RAPP | Rapport Therapeutics, Inc. | 1.54B | -0.42% | 660,151 | 20.00M |
| 307 | CNMD | CONMED Corporation | 1.53B | -1.41% | 225,159 | 1.37B |
| 308 | ADRX | ADARx Pharmaceuticals, Inc. | 1.52B | -1.67% | 289,837 | 6.13M |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | 5.10% | 1,188,615 | 1.04B |
| 310 | DMRA | Damora Therapeutics, Inc. | 1.49B | 0.33% | 466,097 | - |
| 311 | NUVB | Nuvation Bio Inc. | 1.48B | -3.45% | 3,479,164 | 201.73M |
| 312 | USPH | U.S. Physical Therapy, Inc. | 1.48B | -0.60% | 177,425 | 829.86M |
| 313 | PCRX | Pacira BioSciences, Inc. | 1.46B | 0.08% | 1,877,288 | 743.30M |
| 314 | AMN | AMN Healthcare Services, Inc. | 1.46B | 0.27% | 683,879 | 3.52B |
| 315 | LBRX | LB Pharmaceuticals Inc | 1.45B | -0.40% | 377,883 | - |
| 316 | OCUL | Ocular Therapeutix, Inc. | 1.45B | -3.50% | 2,657,851 | 50.38M |
| 317 | TYRA | Tyra Biosciences, Inc. | 1.45B | -5.83% | 793,827 | - |
| 318 | ANAB | AnaptysBio, Inc. | 1.45B | 0.85% | 244,930 | 106.09M |
| 319 | KARD | Kardigan, Inc. | 1.42B | - | 769,733 | - |
| 320 | KRSA | Korsana Biosciences, Inc. | 1.42B | -0.19% | 383,991 | - |
| 321 | PAHC | Phibro Animal Health Corporation | 1.41B | 0.09% | 223,792 | 1.54B |
| 322 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | -2.17% | 2,083,006 | 5.49M |
| 323 | AVLN | Avalyn Pharma Inc. | 1.38B | 5.66% | 478,190 | - |
| 324 | NVCR | NovoCure Limited | 1.38B | -5.75% | 1,929,015 | 725.39M |
| 325 | MLYS | Mineralys Therapeutics, Inc. | 1.37B | -1.83% | 1,718,595 | - |
| 326 | AAPG | Ascentage Pharma Group International | 1.37B | 0.91% | 1,576 | 94.61M |
| 327 | MNKD | MannKind Corporation | 1.36B | 0.95% | 4,113,191 | 413.37M |
| 328 | INVA | Innoviva, Inc. | 1.36B | 0.42% | 786,121 | 438.32M |
| 329 | GHRS | GH Research PLC | 1.34B | 1.56% | 108,744 | - |
| 330 | LMRI | Lumexa Imaging Holdings, Inc. | 1.34B | -0.36% | 384,751 | 1.06B |
| 331 | INBX | Inhibrx Biosciences, Inc. | 1.33B | -1.23% | 100,296 | 1.30M |
| 332 | PRCT | PROCEPT BioRobotics Corporation | 1.33B | 3.04% | 1,789,790 | 352.31M |
| 333 | SVRA | Savara Inc. | 1.32B | -2.57% | 1,730,116 | - |
| 334 | CMPS | COMPASS Pathways plc | 1.31B | 0.76% | 2,641,111 | - |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | 2.97% | 2,724,518 | 1.08B |
| 336 | PNTG | The Pennant Group, Inc. | 1.29B | 1.32% | 611,211 | 1.17B |
| 337 | NKTR | Nektar Therapeutics | 1.29B | -0.13% | 417,515 | 54.59M |
| 338 | INNV | InnovAge Holding Corp. | 1.28B | 1.74% | 562,756 | 1.02B |
| 339 | NUTX | Nutex Health Inc. | 1.28B | -4.07% | 96,187 | 796.53M |
| 340 | OPK | OPKO Health, Inc. | 1.27B | - | 2,439,426 | 654.10M |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.26B | -2.91% | 427,002 | - |
| 342 | CRON | Cronos Group Inc. | 1.26B | -3.67% | 1,044,848 | 206.20M |
| 343 | OMER | Omeros Corporation | 1.25B | -1.42% | 683,729 | 38.42M |
| 344 | URGN | UroGen Pharma Ltd. | 1.24B | -3.76% | 740,072 | 250.25M |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.24B | -1.09% | 484,893 | 745.79M |
| 346 | SLN | Silence Therapeutics plc | 1.23B | 0.20% | 827,884 | 615.00K |
| 347 | GDRX | GoodRx Holdings, Inc. | 1.21B | -3.01% | 977,579 | 785.23M |
| 348 | VOR | Vor Biopharma Inc. | 1.20B | -2.10% | 405,831 | - |
| 349 | STAA | STAAR Surgical Company | 1.20B | -2.77% | 1,812,457 | 328.27M |
| 350 | SPTX | Seaport Therapeutics, Inc. | 1.18B | 0.18% | 301,047 | - |
| 351 | FRNM | Freenome, Inc. | 1.16B | 1.89% | 705,295 | 217.86M |
| 352 | SGP | SpyGlass Pharma, Inc. | 1.14B | -10.92% | 94,128 | - |
| 353 | HROW | Harrow, Inc. | 1.14B | 10.52% | 2,153,421 | 303.25M |
| 354 | SIBN | SI-BONE, Inc. | 1.13B | -1.95% | 745,274 | 220.65M |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.13B | 1.11% | 1,770,753 | 1.66B |
| 356 | ANRO | Alto Neuroscience, Inc. | 1.12B | 2.91% | 515,840 | - |
| 357 | IRMD | IRADIMED CORPORATION | 1.11B | -0.25% | 129,207 | 89.34M |
| 358 | VSTM | Verastem, Inc. | 1.10B | 0.34% | 2,953,239 | 100.30M |
| 359 | ATEC | Alphatec Holdings, Inc. | 1.09B | -5.15% | 4,659,099 | 839.72M |
| 360 | AHG | Akso Health Group | 1.07B | -2.45% | 7,147 | 13.83M |
| 361 | MLTX | MoonLake Immunotherapeutics | 1.07B | -0.48% | 909,175 | - |
| 362 | CBLL | CeriBell, Inc. | 1.07B | -0.43% | 327,274 | 108.72M |
| 363 | CSTL | Castle Biosciences, Inc. | 1.06B | 0.12% | 407,939 | 377.13M |
| 364 | JBIO | Jade Biosciences, Inc. | 1.04B | 5.13% | 895,168 | - |
| 365 | AHCO | AdaptHealth Corp. | 1.03B | 5.03% | 1,682,411 | 3.44B |
| 366 | AORT | Artivion, Inc. | 998.73M | -0.82% | 997,937 | 481.88M |
| 367 | GMRS | GMR Solutions Inc. | 993.48M | -2.48% | 3,201,095 | 5.97B |
| 368 | CTY | City Therapeutics, Inc. | 976.23M | 5.09% | 423,481 | 14.34M |
| 369 | AKTS | Aktis Oncology, Inc. | 970.56M | 6.60% | 463,610 | 10.06M |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 959.10M | 0.18% | 950,785 | - |
| 371 | ODTX | Odyssey Therapeutics, Inc. | 958.82M | 4.44% | 395,008 | 99.00K |
| 372 | BVS | Bioventus Inc. | 942.04M | 1.45% | 616,244 | 585.64M |
| 373 | OMDA | Omada Health, Inc. | 934.29M | -0.20% | 2,223,701 | 333.04M |
| 374 | MGTX | MeiraGTx Holdings plc | 923.93M | 1.37% | 774,744 | 397.50M |
| 375 | ORIC | ORIC Pharmaceuticals, Inc. | 923.55M | -3.47% | 1,011,308 | - |
| 376 | PHAR | Pharming Group N.V. | 921.43M | 0.46% | 7,104 | 386.75M |
| 377 | BBNX | Beta Bionics, Inc. | 898.14M | -2.54% | 658,983 | 127.27M |
| 378 | GLUE | Monte Rosa Therapeutics, Inc. | 897.23M | -0.76% | 1,506,497 | 70.33M |
| 379 | IVA | Inventiva S.A. | 885.26M | 2.86% | 2,263,569 | 2.81M |
| 380 | LTGO | Latigo Biotherapeutics, Inc. | 883.77M | -0.15% | 780,388 | - |
| 381 | HSTM | HealthStream, Inc. | 879.47M | -0.49% | 288,303 | 327.95M |
| 382 | IMTX | Immatics N.V. | 877.55M | -0.16% | 1,221,137 | 49.33M |
| 383 | KIDS | OrthoPediatrics Corp. | 874.18M | -1.50% | 249,020 | 264.14M |
| 384 | BBTX | Bambusa Therapeutics, Inc. | 868.57M | 0.65% | 134,297 | - |
| 385 | SNDX | Syndax Pharmaceuticals, Inc. | 854.37M | -0.63% | 2,942,812 | 289.68M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 848.76M | 0.22% | 744,001 | - |
| 387 | ALMS | Alumis Inc. | 828.39M | -2.29% | 1,542,125 | 7.40M |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 828.14M | 2.20% | 3,405,512 | 38.54M |
| 389 | RIGL | Rigel Pharmaceuticals, Inc. | 826.82M | 4.42% | 249,588 | 288.21M |
| 390 | PHR | Phreesia, Inc. | 814.99M | 1.78% | 516,133 | 507.79M |
| 391 | ANNX | Annexon, Inc. | 803.12M | -0.47% | 4,596,588 | - |
| 392 | SLDB | Solid Biosciences Inc. | 800.25M | 2.14% | 1,721,859 | - |
| 393 | IRWD | Ironwood Pharmaceuticals, Inc. | 796.30M | 2.78% | 4,594,417 | 400.30M |
| 394 | AURA | Aura Biosciences, Inc. | 796.17M | -0.13% | 875,183 | - |
| 395 | QDEL | QuidelOrtho Corporation | 790.42M | -4.71% | 2,524,522 | 2.59B |
| 396 | DNA | Ginkgo Bioworks Holdings, Inc. | 778.55M | -2.91% | 1,469,927 | 130.75M |
| 397 | VREX | Varex Imaging Corporation | 777.63M | - | 374,550 | 865.00M |
| 398 | SGMT | Sagimet Biosciences Inc. | 772.20M | 0.55% | 1,573,275 | - |
| 399 | INMD | InMode Ltd. | 762.48M | -1.81% | 786,240 | 374.63M |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 760.42M | -0.97% | 851,839 | 815.19M |
| 401 | ATTO | Attovia Therapeutics, Inc. | 759.64M | 4.26% | 185,584 | 1.44M |
| 402 | CTKB | Cytek Biosciences, Inc. | 757.24M | -1.70% | 2,216,775 | 207.65M |
| 403 | ARDX | Ardelyx, Inc. | 756.63M | 2.73% | 5,466,468 | 468.22M |
| 404 | OABI | OmniAb, Inc. | 743.89M | -3.77% | 1,754,378 | 40.21M |
| 405 | JANX | Janux Therapeutics, Inc. | 736.65M | -5.64% | 2,354,816 | 23.29M |
| 406 | CGEM | Cullinan Therapeutics, Inc. | 729.06M | -4.26% | 810,429 | - |
| 407 | SANA | Sana Biotechnology, Inc. | 728.11M | -1.42% | 2,537,509 | - |
| 408 | NVCT | Nuvectis Pharma, Inc. | 724.92M | 0.29% | 201,682 | - |
| 409 | FLGT | Fulgent Genetics, Inc. | 720.27M | -1.41% | 617,163 | 330.28M |
| 410 | CADL | Candel Therapeutics, Inc. | 715.45M | -1.48% | 623,545 | - |
| 411 | ZVRA | Zevra Therapeutics, Inc. | 709.30M | -1.81% | 1,063,516 | 147.76M |
| 412 | DBVT | DBV Technologies S.A. | 702.82M | 4.16% | 162,616 | 3.74M |
| 413 | PACB | Pacific Biosciences of California, Inc. | 700.96M | -5.08% | 8,885,082 | 161.39M |
| 414 | IAM | Iambic Therapeutics, Inc. | 700.58M | 10.46% | 867,820 | 18.25M |
| 415 | DCTH | Delcath Systems, Inc. | 699.24M | -0.84% | 2,287,208 | 109.96M |
| 416 | AVBP | ArriVent BioPharma, Inc. | 697.74M | -4.73% | 776,297 | 5.00M |
| 417 | PRME | Prime Medicine, Inc. | 693.83M | -9.30% | 4,508,380 | 4.07M |
| 418 | IMMX | Immix Biopharma, Inc. | 692.24M | -2.57% | 825,479 | - |
| 419 | CLYM | Climb Bio, Inc. | 689.59M | 6.63% | 1,568,300 | - |
| 420 | FDMT | 4D Molecular Therapeutics, Inc. | 688.34M | -0.16% | 1,075,502 | 92.01M |
| 421 | DSGN | Design Therapeutics, Inc. | 681.99M | -1.39% | 264,894 | - |
| 422 | BCAX | Bicara Therapeutics Inc. | 675.82M | 2.00% | 1,951,087 | - |
| 423 | KURA | Kura Oncology, Inc. | 673.43M | - | 2,502,493 | 79.31M |
| 424 | SOPH | SOPHiA GENETICS SA | 673.27M | 4.94% | 919,033 | 90.97M |
| 425 | WVE | Wave Life Sciences, Inc. | 672.55M | -2.01% | 1,400,851 | 70.92M |
| 426 | HELP | Helus Pharma Inc. | 662.66M | -3.20% | 1,141,259 | - |
| 427 | APMD | Apnimed, Inc. | 660.26M | 0.32% | 378,260 | 115.12M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 658.24M | -2.12% | 1,397,434 | 6.40M |
| 429 | ANL | Adlai Nortye Group Ltd. | 641.40M | -10.67% | 377,006 | 18.06M |
| 430 | OLMA | Olema Pharmaceuticals, Inc. | 636.90M | -1.22% | 935,309 | - |
| 431 | GERN | Geron Corporation | 627.62M | -2.24% | 12,511,393 | 217.52M |
| 432 | SRZN | Surrozen, Inc. | 622.17M | 2.00% | 197,896 | 10.53M |
| 433 | EVO | Evotec SE | 618.00M | -2.87% | 84,933 | 815.72M |
| 434 | SGHT | Sight Sciences, Inc. | 597.47M | -2.36% | 466,954 | 88.40M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 596.32M | 0.11% | 206,779 | 356.42M |
| 436 | CBIO | Crescent Biopharma, Inc. | 595.79M | 1.98% | 168,277 | 11.88M |
| 437 | ABUS | Arbutus Biopharma Corporation | 585.58M | 2.69% | 2,287,478 | 181.49M |
| 438 | AVR | Anteris Technologies Global Corp. | 574.24M | -0.84% | 779,559 | 2.33M |
| 439 | NRC | NRC Health | 569.80M | 0.67% | 129,213 | 143.79M |
| 440 | ENTX | Entera Bio Ltd. | 563.51M | -0.31% | 98,554 | 42.00K |
| 441 | VALN | Valneva SE | 549.68M | 3.71% | 24,429 | 163.30M |
| 442 | SENS | Senseonics Holdings, Inc. | 549.45M | 2.35% | 4,671,627 | 60.01M |
| 443 | TKNO | Alpha Teknova, Inc. | 549.14M | 2.11% | 382,015 | 45.95M |
| 444 | RCEL | AVITA Medical, Inc. | 545.86M | 3.10% | 858,209 | 84.68M |
| 445 | MYGN | Myriad Genetics, Inc. | 543.88M | -1.22% | 1,157,257 | 803.60M |
| 446 | EVH | Evolent Health, Inc. | 542.91M | 1.91% | 1,749,983 | 2.34B |
| 447 | SRTA | Strata Critical Medical, Inc. | 537.71M | -0.50% | 1,668,726 | 280.76M |
| 448 | OVID | Ovid Therapeutics Inc. | 528.45M | -1.75% | 2,307,807 | 1.45M |
| 449 | NGNE | Neurogene Inc. | 523.32M | -2.77% | 344,521 | 925.00K |
| 450 | DMAC | DiaMedica Therapeutics Inc. | 521.46M | 0.21% | 144,932 | - |
| 451 | CAPR | Capricor Therapeutics, Inc. | 515.69M | -9.95% | 4,535,747 | 11.13M |
| 452 | SLBT | SL Science Holding Limited | 512.67M | -8.12% | 21,670 | 3.27M |
| 453 | RGNX | REGENXBIO Inc. | 508.48M | -4.71% | 1,084,413 | 153.91M |
| 454 | ANGO | AngioDynamics, Inc. | 507.60M | -0.41% | 339,579 | 325.38M |
| 455 | EPRX | Eupraxia Pharmaceuticals Inc. | 503.85M | 2.83% | 476,717 | - |
| 456 | ETRA | Electra Therapeutics, Inc. | 501.51M | -2.80% | 298,185 | - |
| 457 | STTK | Shattuck Labs, Inc. | 493.94M | -2.81% | 734,971 | 1.00M |
| 458 | MDXG | MiMedx Group, Inc. | 491.77M | 1.51% | 1,159,249 | 303.73M |
| 459 | CTEV | Claritev Corporation | 489.53M | 19.46% | 933,121 | 1.02B |
| 460 | MNPR | Monopar Therapeutics Inc. | 481.80M | -2.67% | 88,213 | - |
| 461 | OCS | Oculis Holding AG | 468.55M | -2.19% | 266,852 | 1.12M |
| 462 | GYRE | Gyre Therapeutics, Inc. | 462.98M | -9.03% | 141,063 | 110.06M |
| 463 | KMDA | Kamada Ltd. | 461.95M | 5.06% | 206,790 | 196.87M |
| 464 | SI | Shoulder Innovations, Inc. | 458.83M | 2.19% | 172,071 | 64.49M |
| 465 | RLMD | Relmada Therapeutics, Inc. | 455.48M | 3.14% | 985,677 | - |
| 466 | ARVN | Arvinas, Inc. | 453.16M | 2.37% | 702,748 | 275.30M |
| 467 | BLSM | BlossomHill Therapeutics, Inc. | 452.62M | -1.52% | 175,886 | - |
| 468 | OBIO | Orchestra BioMed Holdings, Inc. | 450.97M | 0.53% | 485,540 | 31.21M |
| 469 | EOLS | Evolus, Inc. | 450.74M | -2.44% | 5,816,222 | 325.47M |
| 470 | INDP | Indaptus Therapeutics, Inc. | 445.39M | -7.35% | 475,065 | - |
| 471 | STLN | Starling Oncology, Inc. | 442.64M | 8.50% | 6,453,945 | 620.45M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 442.42M | -0.56% | 2,559,054 | 48.84M |
| 473 | BWAY | BrainsWay Ltd. | 440.15M | -8.33% | 497,684 | 60.70M |
| 474 | PRTA | Prothena Corporation plc | 439.55M | -2.51% | 394,177 | 52.74M |
| 475 | NPCE | NeuroPace, Inc. | 435.58M | -3.28% | 133,743 | 106.99M |
| 476 | ASMB | Assembly Biosciences, Inc. | 434.70M | -2.02% | 263,293 | 74.85M |
| 477 | PHAT | Phathom Pharmaceuticals, Inc. | 432.50M | 2.16% | 1,506,619 | 274.88M |
| 478 | CTMX | CytomX Therapeutics, Inc. | 431.65M | - | 16,652,910 | 14.03M |
| 479 | TECX | Tectonic Therapeutic, Inc. | 429.50M | 0.37% | 192,786 | - |
| 480 | YDES | YD Bio Limited | 427.11M | -10.13% | 104,807 | 1.24M |
| 481 | RZLT | Rezolute, Inc. | 421.71M | 3.88% | 1,605,341 | - |
| 482 | PBYI | Puma Biotechnology, Inc. | 420.82M | -3.10% | 602,373 | 231.83M |
| 483 | CRMD | CorMedix Inc. | 418.56M | -1.83% | 2,341,749 | 462.25M |
| 484 | CTNM | Contineum Therapeutics, Inc. | 414.65M | 2.52% | 249,721 | - |
| 485 | AVTX | Avalo Therapeutics, Inc. | 414.01M | -1.51% | 4,273,212 | 59.00K |
| 486 | MPLT | MapLight Therapeutics, Inc. | 413.48M | 2.20% | 460,528 | - |
| 487 | MASS | 908 Devices Inc. | 412.72M | -13.25% | 898,551 | 65.79M |
| 488 | LYEL | Lyell Immunopharma, Inc. | 411.81M | 8.63% | 228,305 | 15.00K |
| 489 | MOBI | Mobia Medical, Inc. | 406.60M | -0.49% | 175,818 | 51.89M |
| 490 | IRD | Opus Genetics, Inc. | 405.23M | 0.71% | 1,070,932 | 7.91M |
| 491 | CARL | Carlsmed, Inc. | 403.11M | -8.35% | 109,343 | 71.78M |
| 492 | CCCC | C4 Therapeutics, Inc. | 393.95M | -4.76% | 1,453,874 | 32.28M |
| 493 | CERS | Cerus Corporation | 393.81M | -5.80% | 6,337,173 | 226.57M |
| 494 | TLRY | Tilray Brands, Inc. | 388.66M | -7.02% | 4,340,933 | 963.10M |
| 495 | PRLD | Prelude Therapeutics Incorporated | 387.26M | - | 388,398 | 22.42M |
| 496 | EDIT | Editas Medicine, Inc. | 386.62M | -8.91% | 1,589,941 | 49.83M |
| 497 | ALT | Altimmune, Inc. | 377.36M | -8.49% | 3,995,329 | 31.00K |
| 498 | ALEC | Alector, Inc. | 376.66M | 2.85% | 3,258,547 | 173.47M |
| 499 | ASPE | Aspen Neuroscience, Inc. | 372.50M | 3.31% | 279,364 | - |
| 500 | FENC | Fennec Pharmaceuticals Inc. | 371.01M | -2.31% | 228,388 | 59.22M |